Intravitreal bevacizumab for CNV-complicated tilted disk syndrome

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 9, 2009, Pages 1179-1182

  Milani, Paolo ^a   Pece, Alfredo ^b   Moretti, Giuseppe ^a   Lino, Pruneri ^a   Scialdone, Antonio ^a  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b Ospedale Predabissi   (Italy)

Author keywords

Avastin; Bevacizumab; CNV; Intravitreal; Neovascularisation; OCT; Tilted disk

Indexed keywords

BEVACIZUMAB;

AGED; ARTICLE; CASE REPORT; CHORIORETINOPATHY; CHOROID CAPILLARY LAYER; DIAGNOSTIC IMAGING; DRUG RESPONSE; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; OFF LABEL DRUG USE; OPHTHALMOSCOPY; OPTIC DISK ANOMALY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA FOVEA; RETINA HEMORRHAGE; SUBRETINAL NEOVASCULARIZATION; TILTED OPTIC DISK; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; EYE ABNORMALITIES; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MALE; OPTIC DISK; SYNDROME; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 68549130629     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1096-4     Document Type: Article

References (12)

1. Apple DJ, Rabb MF, Walsh PM (1982) Congenital anomalies of the optic disc. Surv Ophthalmol 27(1):3-41. doi: 10.1016/0039-6257(82)90111-4
2. Dorrell D (1978) The tilted disc. Br J Ophthalmol 62(1):16-20. doi: 10.1136/bjo.62.1.16
3. Vongphanit J, Mitchell P, Wang JJ (2002) Population prevalence of tilted optic disks and the relationship of this sign to refractive error. Am J Ophthalmol 133(5):679-685. doi: 10.1016/S0002-9394(02)01339-9
4. Cohen SY, Quentel G, Guiberteau B, Delahaye-Mazza C, Gaudric A (1998) Macular serous retinal detachment caused by subretinal leakage in tilted disc syndrome. Ophthalmology 105(10):1831-1834. doi: 10.1016/ S0161-6420(98)91024-7
5. Stur M (1988) Congenital tilted disk syndrome associated with parafoveal subretinal neovascularization. Am J Ophthalmol 105(1):98-99
6. Prost M, De Laey JJ (1988) Choroidal neovascularization in tilted disc syndrome. Int Ophthalmol 12(2):131-135. doi: 10.1007/BF00137139
7. Nakanishi H, Tsujikawa A, Gotoh N, Hayashi H, Iwama D, Tamura H, Otani A, Yoshimura N (2008) Macular complications on the border of an inferior staphyloma associated with tilted disk syndrome. Retina 28(10):1493-1501. doi: 10.1097/IAE.0b013e318183589c
8. Arias L, Planas N, Prades S, Caminal JM, Rubio M, Pujol O, Roca G (2008) Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results. Br J Ophthalmol 92(8):1035-1039. doi: 10.1136/bjo.2007.130260
9. Chan WM, Lai TY, Liu DT, Lam DS (2007) Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: Six-month results of a prospective pilot study. Ophthalmology 114(12):2190-2196. doi: 10.1016/ j.ophtha.2007.03.043
10. Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB (2009) Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results. Am J Ophthalmol 147(1):84-93
11. Ikuno Y, Sayanagi K, Soga K, Sawa M, Tsujikawa M, Gomi F, Tano Y (2009) Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: One-year results. Am J Ophthalmol 147(1):94-100
12. Pece A, Isola V, Vadalà M, Matranga D (2006) Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: Long-term study. Retina 26(7):746-751. doi: 10.1097/ 01.iae.0000244256.60524.c0